Search results
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 3 days ago“These are drugs we’ve used forever.” But what...Old and underpriced Few people in the country know...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 3 hours agoAs a result, many large pharma companies are present in Brazil and have expansion plans. Merck...Rio de Janeiro. In February 2024, the pharma company...
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
WSAU Wausau· 5 days ago(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged ...
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 7 days agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
Zacks via Yahoo Finance· 7 days agoNew drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks...
Indian drugmaker Cipla beats Q4 profit estimates on strong US demand
WHTC 1450 Holland· 3 days agoBENGALURU (Reuters) - Cipla, India's third-largest generic drugmaker by sales, reported fourth-quarter profit above expectations on Friday, driven by strong demand for its ...
Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High
Investor's Business Daily· 5 days agoThe company expects Austedo to generate $2.5 billion in revenue by 2027, according to the...
Teva Pharm Q1 profit misses estimates, revenue risea
AOL· 5 days agoThe world's largest generic drugmaker said on Wednesday it earned 48 cents per diluted share excluding one-time items in the January-March quarter, up from 40 cents per share ...
Cancer Drug Price-Cutting Pitch Mulled by HHS as Industry Waits
Bloomberg Law· 3 days agoThe Biden administration is weighing a drug pricing control proposition that attorneys and industry watchers say could bolster efforts to lower prescription costs even if ...
William Blair Commentary- Large-Cap Growth: Managing Risk and Seeking Consistent Returns
GuruFocus.com via Yahoo Finance· 6 days agoWhile large-cap companies in the biopharmaceutical industry may benefit from sizable revenue streams...
